Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 270 No 7231 p39-45
11 January 2003


News summary

Research & Development  |  Branch meetings   Future Events   Conferences

39 Welsh Assembly earmarks £500,000 for automated dispensing in hospitals The National Assembly for Wales is to spend £500,000 installing automated dispensing robots at three hospital pharmacies in the next financial year...[more]

39 Ricin found by police during raids on flats in London Ricin, a protein toxin derived from the beans of the castor oil plant, was discovered by officers from the Metropolitan Police anti-terrorism branch during raids on premises in north and east London on 5 January...[more]

40 Department of Health's skill mix paper shows limited vision, the PSNC says The Pharmaceutical Services Negotiating Committee has dismissed the Department of Health's skill mix discussion paper as showing little vision of how pharmacists' skills can be used to deliver better care through the National Health Service...[more]

40 Staff shortages hold back skill mix developments, says UNISON Shortages of hospital pharmacy staff are holding back the developments outlined in the Department of Health's skill mix consultation paper, according to UNISON, which represents the majority of National Health Service pharmacy technicians and assistants...[more]

40 NHS Scotland logos sent to pharmacies Community pharmacies in Scotland have been sent stickers and posters to display bearing the National Health Service in Scotland logo...[more]

40 Independent Pharmacists' Association to be launched in Britain in the spring The inaugural meeting of a new Independent Pharmacists' Association is to be held on 6 April...[more]

41 Risk of developing diabetes reduced in women with heart disease taking HRT Women with coronary heart disease who take hormone replacement therapy (HRT) have a substantially reduced risk of developing diabetes, a large randomised controlled trial has shown...[more]

41 Sildenafil effective for sexual dysfunction associated with use of antidepressants Sildenafil (Viagra) is an effective treatment for sexual dysfunction associated with antidepressant use, a study shows...[more]

41 Possible new role for tamoxifen Tamoxifen could be used to stimulate the ovaries of former breast cancer patients who wish to increase their chance of becoming pregnant, say American researchers...[more]

42 Candesartan could help in preventing migraines Candesartan (Amias) could prove to be an effective agent for migraine prophylaxis, according to the results of a small placebo-controlled study...[more]

42 Call for Schering to repay NHS money over Yasmin claims The Consumers' Association has called on Schering Health Care to repay £200,000 to the National Health Service following misleading claims about its oral contraceptive product Yasmin (ethinylestradiol with drospirenone)...[more]

42 Pharmaceutical industry promotions criticised Promotional activities of pharmaceutical companies have been criticised in articles published in two leading medical journals...[more]

43 Celecoxib as good as diclofenac plus omeprazole in gastric bleeds Celecoxib (Celebrex) is as effective as diclofenac plus omeprazole at preventing recurrent bleeds among arthritis patients with a recent history of ulcer bleeding, a randomised controlled trial has shown...[more]

43 Pharmacist supports "women into public life" at Number 10 MADELEINE KEYWORTH, FRPharmS, was one of a number of women invited to a reception hosted by Cherie Blair at 10 Downing Street last month...[more]


Research and Development


44 Selective adhesion molecule inhibitor effective in treating Crohn’s disease ... well as for the treatment of multiple sclerosis NATALIZUMAB (Antegren), a selective adhesion molecule inhibitor, increases rates of clinical response and remission in patients with Crohn’s disease, researchers report...[more]

44 Call to abandon body surface area for dosing anticancer drugs Body surface area should not be used to determine starting doses of anticancer agents in phase I trials, researchers say...[more]

44 Dendritic cell vaccine for HIV? In Nature Medicine this month researchers find that dendritic cell vaccines show promise as a means to control diseases caused by immunodeficiency viruses...[more]

45 Complete remission seen for multiple myeloma with new enzyme inhibitor omplete remission of advanced stage multiple myeloma can be achieved in patients treated with the proteasome inhibitor bortezomib (Velcade), phase II data show...[more]

45 New drug for treating malaria Fosmidomycin, a phosphonic acid derivative, is a safe and effective treatment for uncomplicated malaria in adults, researchers say...[more]

45 Ximelagatran reduces VTE risk Ximelagatran (Exanta), a direct thrombin inhibitor, reduces the risk of recurrent venous thromboembolism (VTE) by 84 per cent over 18 months compared with placebo, new data show...[more]

Back to Top

  * PDF files on PJ Online require Acrobat Reader 4 or later.


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal